Dr. Daines is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
535 N Wilmot Rd
Suite #101
Tucson, AZ 85711Phone+1 520-694-9988Fax+1 520-694-9917
Education & Training
- University of North Carolina HospitalsFellowship, Pediatric Pulmonology, 1996 - 1999
- SSM Health/Saint Louis University School of MedicineResidency, Pediatrics, 1993 - 1996
- Saint Louis University School of MedicineClass of 1993
Certifications & Licensure
- AZ State Medical License 2006 - 2025
- OH State Medical License 1999 - 2007
- NC State Medical License 1996 - 1999
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Pulmonology
Awards, Honors, & Recognition
- Top Doctors:Arizona State Castle Connolly, 2013
Clinical Trials
- Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis Start of enrollment: 2013 Jun 01
- Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic Fibrosis Start of enrollment: 2009 May 01
- OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis Start of enrollment: 2014 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 341 citationsTezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic FibrosisSteven M. Rowe, Cori L. Daines, Felix C. Ringshausen, Eitan Kerem, John W Wilson
The New England Journal of Medicine. 2017-11-03 - 46 citationsRandomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.Richard B. Moss, Nicole Mayer-Hamblett, Jeffrey S. Wagener, Cori L. Daines, Kathryn A Hale
Pediatric Pulmonology. 2005-03-01 - 437 citationsVX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.Dominic Keating, Gautham Marigowda, Lucy D. Burr, Cori L. Daines, Marcus A. Mall
The New England Journal of Medicine. 2018-10-18
Journal Articles
- VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del AllelesCori Daines, Bonnie W Ramsey, The New England Journal of Medicine
- Outcome Measures for Pediatric Laryngotracheal Reconstruction: International Consensus StatementReza Rahbar, Michael J Rutter, Catherine K Hart, Christopher T Wootten, Jonathan B Ida, R Paul Boesch, David R White, Shelagh A Cofer, Karen Zur, Cori Daines, Peter B ..., The Laryngoscope
Press Mentions
- France’s Vaccination-Pass ExperimentAugust 12th, 2021
Grant Support
- Aztreonam For Inhalation In Patients With Cystic FibrosNational Center For Research Resources2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: